BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
nitric oxide metabolic process
,
Lung cancer
,
Embryo
,
Amniocentesis
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pl 100
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Acute myeloid leukemia PL21 and HL60 cells overexpressing pre-miR-150
Time course of 1,25(OH)2D treated RWPE1 cells
Molar tooth germs of E14 mice cultured with or without TCDD
T-ALL MOLT4 cells with CRISPR-Cas9-induced partial or complete gene knockout of USP7
Prostate cancer PC-3 xenografts from mice treated with [D-Lys3]-GHRP-6
Explore Curated Studies Results
Literature
Most Relevant Literature
In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibit…
Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B H…
PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitr…
In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of hu…
Evidence of TWIST1 and transforming growth factor-B1 aberrant expressions as novel therapeutic targe…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Performance Evaluation of T-TAS 01 PL Chip
Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Nebulized PL for Post-COVID-19 Syndrome
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ